Direct Gene Therapy for Bone Regeneration: Gene Delivery, Animal Models, and Outcome Measures
- 1 February 2010
- journal article
- review article
- Published by Mary Ann Liebert Inc in Tissue Engineering, Part B: Reviews
- Vol. 16 (1), 13-20
- https://doi.org/10.1089/ten.teb.2009.0156
Abstract
While various problems with bone healing remain, the greatest clinical change is the absence of an effective approach to manage large segmental defects in limbs and craniofacial bones caused by trauma or cancer. Thus, nontraditional forms of medicine, such as gene therapy, have been investigated as a potential solution. The use of osteogenic genes has shown great potential in bone regeneration and fracture healing. Several methods for gene delivery to the fracture site have been described. The majority of them include a cellular component as the carrying vector, an approach known as cell-mediated gene therapy. Yet, the complexity involved with cell isolation and culture emphasizes the advantages of direct gene delivery as an alternative strategy. Here we review the various approaches of direct gene delivery for bone repair, the choice of animal models, and the various outcome measures required to evaluate the efficiency and safety of each technique. Special emphasis is given to noninvasive, quantitative, in vivo monitoring of gene expression and biodistribution in live animals. Research efforts should aim at inducing a transient, localized osteogenic gene expression within a fracture site to generate an effective therapeutic approach that would eventually lead to clinical use.Keywords
This publication has 85 references indexed in Scilit:
- Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic MelanomaJournal of Clinical Oncology, 2008
- The effect of surface demineralization of cortical bone allograft on the properties of recombinant adeno-associated virus coatingsBiomaterials, 2008
- Phenotypic and Functional Analysis of Dendritic Cells and Clinical Outcome in Patients With High-Risk Melanoma Treated With Adjuvant Granulocyte Macrophage Colony-Stimulating FactorJournal of Clinical Oncology, 2008
- Tumor Ablation with Irreversible ElectroporationPLOS ONE, 2007
- Human reporter genes: potential use in clinical studiesNuclear Medicine and Biology, 2007
- Healing of Segmental Bone Defects by Direct Percutaneous Gene Delivery: Effect of Vector DoseHuman Gene Therapy, 2007
- Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defectsGene Therapy, 2007
- Direct Percutaneous Gene Delivery to Enhance Healing of Segmental Bone DefectsThe Journal of Bone & Joint Surgery, 2006
- Molecular Imaging of the Skeleton: Quantitative Real-Time Bioluminescence Monitoring Gene Expression in Bone Repair and DevelopmentJournal of Bone and Mineral Research, 2003
- TrueGene Therapy, 2000